Menu
OR
OR
Prosthesis-Patient Mismatch and Patient-Centered Outcomes After TAVR

Cardiology

...

9 November, 2026

JACC Cardiovasc Interv. 2026 Nov 9;19(21):2857-2871. doi: 10.1016/j.jcin.2026.07.049.

ABSTRACT

BACKGROUND: Prosthesis-patient mismatch (PPM) after transcatheter aortic valve replacement has been widely studied for its association with clinical outcomes, but its effect on patient-reported health status remains less defined.

OBJECTIVES: This study sought to evaluate the association between PPM severity and health status through 3-year follow-up after transcatheter aortic valve replacement.

METHODS: This post hoc analysis of the SCOPE I (Safety and Efficacy of the ACURATE Neo/TF Compared to the SAPIEN 3 Bioprosthesis) randomized trial categorized patients according to PPM severity using Valve Academic Research Consortium-3 criteria. Endpoints included survival and patient-reported health status, with an integrated outcome defined as being alive with good health status (Kansas City Cardiomyopathy Questionnaire Overall Summary score ≥75 without a decline of >10 points from baseline).

RESULTS: Among 662 patients, moderate and severe PPM occurred in 184 (27.8%) and 69 (10.4%), respectively. All-cause mortality at 1 and 3 years was 7.0% and 20.5%, with no differences across PPM categories. Kansas City Cardiomyopathy Questionnaire Overall Summary score was similar through 1 year but lower at 3 years in patients with severe vs no PPM (median 71.1 vs 83.9; P = 0.027). Fewer patients with severe PPM were alive with good health status at 3 years (30.6% vs 49.4%; P = 0.021). In multivariable analysis, severe PPM was associated with a lower likelihood of the integrated outcome (OR: 0.51; 95% CI: 0.27-0.96; P = 0.036), but this association was no longer statistically significant after adjustment for 30-day mitral regurgitation (OR: 0.59; 95% CI: 0.30-1.15; P = 0.121).

CONCLUSIONS: Among survivors, severe PPM was associated with a lower likelihood of good health status at 3 years. This association was attenuated after accounting for 30-day residual mitral regurgitation, suggesting a possible contributory role. Given the post hoc design, the findings are hypothesis-generating.

PMID:43003597 | DOI:10.1016/j.jcin.2026.07.049

Read Full Article

Journal Source :

JACC: Cardiovascular Interventions

© 2026 Imedsource, All Rights Reserved

Sustain the Knowledge Stream!

For unrestricted access to content and a seamless experience,

Continue to Login

Don't have an account?

We’d love to get to know you better!

Complete your profile to help us deliver a more personalized experience.